Literature DB >> 6089752

The allosteric properties of rat liver fructose-1,6-bisphosphatase.

D W Meek, H G Nimmo.   

Abstract

Inhibition of rat liver fructose-1,6-bisphosphatase by AMP was uncompetitive with respect to fructose 1,6-bisphosphate in the absence of fructose 2,6-bisphosphate, but non-competitive in its presence. AMP was unable to bind to the enzyme except in the presence of one of the fructose bisphosphates; the binding stoicheiometry was 2 molecules/tetramer. Increasing concentrations of Mg2+ increased the Hill coefficient h and the apparent Ki for AMP, whereas fructose 2,6-bisphosphate had the opposite effect. Increasing concentrations of both AMP and fructose 2,6-bisphosphate decreased h and increased the apparent Ka for Mg2+. AMP slightly decreased, and Mg2+ slightly increased, the apparent Ki for fructose 2,6-bisphosphate, but each had only small effects on h. These results are interpreted in terms of a new three-state model for the allosteric properties of the enzyme, in which fructose 2,6-bisphosphate can bind both to the catalytic site and to an allosteric site and AMP can bind to the enzyme only when the catalytic site is occupied.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6089752      PMCID: PMC1144153          DOI: 10.1042/bj2220131

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  The purification of properties of rat liver fructose 1,6-bisphosphatase.

Authors:  G A Tejwani; F O Pedrosa; S Pontremoli; B L Horecker
Journal:  Arch Biochem Biophys       Date:  1976-11       Impact factor: 4.013

2.  ALLOSTERIC INHIBITION OF RAT LIVER FRUCTOSE 1,6-DIPHOSPHATASE BY ADENOSINE 5'-MONOPHOSPHATE.

Authors:  K TAKETA; B M POGELL
Journal:  J Biol Chem       Date:  1965-02       Impact factor: 5.157

3.  ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.

Authors:  J MONOD; J WYMAN; J P CHANGEUX
Journal:  J Mol Biol       Date:  1965-05       Impact factor: 5.469

4.  The effect of pH on the kinetics of beef-liver fructose bisphosphatase.

Authors:  H G Nimmo; K F Tipton
Journal:  Eur J Biochem       Date:  1975-10-15

5.  A multichamber equilibrium dialysis apparatus.

Authors:  C E Furlong; R G Morris; M Kandrach; B P Rosen
Journal:  Anal Biochem       Date:  1972-06       Impact factor: 3.365

6.  The role of fructose 2,6-bisphosphate in regulation of fructose-1,6-bisphosphatase.

Authors:  S J Pilkis; M R El-Maghrabi; M M McGrane; J Pilkis; T H Claus
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

7.  Studies on the mechanism of interaction of fructose 2,6-bisphosphate with fructose-1,6-bisphosphatase.

Authors:  M E Gottschalk; T Chatterjee; I Edelstein; F Marcus
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

8.  The allosteric properties of beef-liver fructose bisphosphatase.

Authors:  H G Nimmo; K F Tipton
Journal:  Eur J Biochem       Date:  1975-10-15

9.  Inhibition of fructose-1,6-bisphosphatase by fructose 2,6-bisphosphate.

Authors:  S J Pilkis; M R El-Maghrabi; J Pilkis; T Claus
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

10.  Inhibition of fructose-1,6-bisphosphatase by fructose 2,6-biphosphate.

Authors:  E Van Schaftingen; H G Hers
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more
  3 in total

1.  Effects of phosphorylation on the kinetic properties of rat liver fructose-1,6-bisphosphatase.

Authors:  D W Meek; H G Nimmo
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

2.  Kinetic properties of D-fructose-1,6-bisphosphate 1-phosphohydrolase isolated from human muscle.

Authors:  K Skalecki; W Mularczyk; A Dzugaj
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

3.  Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.

Authors:  Varman T Samuel; Sara A Beddow; Takanori Iwasaki; Xian-Man Zhang; Xin Chu; Christopher D Still; Glenn S Gerhard; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-08       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.